Is Octreotide legal in Australia?

Octreotide in Australia at a glance

Classification and note come from the Octreotide profile, checked against Therapeutic Goods Administration (TGA) listings at the reviewed date.

What this means

• 01

  TGA has approved Octreotide for at least one labeled indication, so a pharmaceutical-grade product exists in Australia and is dispensed on prescription.

• 02

  Approval is indication-specific. Uses outside the label are a clinical decision for a prescriber, not something the approval itself authorizes.

• 03

  Unlicensed online vials, including those labeled "research use only", are not the approved product and are not covered by the approval.

What Octreotide is

An FDA-approved long-acting somatostatin analogue used for acromegaly and hormone-secreting tumors.

Octreotide is a synthetic analogue of somatostatin engineered to last far longer than the native hormone. It is FDA-approved as Sandostatin for acromegaly (growth hormone excess) and for symptoms of certain neuroendocrine tumors such as carcinoid.

Mechanism: Activates somatostatin receptors to suppress growth hormone and multiple gut and pancreatic hormones.

Regulatory history: FDA-approved (Sandostatin)

How TGA treats this kind of product

Registers or lists therapeutic goods on the ARTG and schedules substances in the Poisons Standard. Many peptides are Schedule 4 (prescription only), so possession without a prescription and personal importation are restricted even when no product is registered.

The classification above is the The Longevity Archive reading of Therapeutic Goods Administration listings for Octreotide at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.

Octreotide in other countries

Frequently asked questions

Related compounds in Australia